Boryung Balance Sheet Health
Financial Health criteria checks 6/6
Boryung has a total shareholder equity of ₩590.2B and total debt of ₩203.3B, which brings its debt-to-equity ratio to 34.4%. Its total assets and total liabilities are ₩1,029.7B and ₩439.5B respectively. Boryung's EBIT is ₩69.1B making its interest coverage ratio 8. It has cash and short-term investments of ₩29.1B.
Key information
34.4%
Debt to equity ratio
₩203.26b
Debt
| Interest coverage ratio | 8x |
| Cash | ₩29.10b |
| Equity | ₩590.17b |
| Total liabilities | ₩439.48b |
| Total assets | ₩1.03t |
Recent financial health updates
Boryung Pharmaceutical (KRX:003850) Has A Pretty Healthy Balance Sheet
Mar 17
Is Boryung Pharmaceutical (KRX:003850) A Risky Investment?
Dec 08
Recent updates
Earnings Not Telling The Story For Boryung Corporation (KRX:003850)
Aug 05Why We're Not Concerned About Boryung Corporation's (KRX:003850) Share Price
Apr 06A Look At The Fair Value Of Boryung Pharmaceutical Co., Ltd. (KRX:003850)
Apr 28Boryung Pharmaceutical (KRX:003850) Has A Pretty Healthy Balance Sheet
Mar 17Here's How We Evaluate Boryung Pharmaceutical Co., Ltd.'s (KRX:003850) Dividend
Feb 27Is Boryung Pharmaceutical Co., Ltd.'s (KRX:003850) Recent Stock Performance Influenced By Its Fundamentals In Any Way?
Feb 09Do Institutions Own Boryung Pharmaceutical Co., Ltd. (KRX:003850) Shares?
Jan 25Should You Use Boryung Pharmaceutical's (KRX:003850) Statutory Earnings To Analyse It?
Jan 10If You Had Bought Boryung Pharmaceutical (KRX:003850) Shares Three Years Ago You'd Have Earned 122% Returns
Dec 23Is Boryung Pharmaceutical (KRX:003850) A Risky Investment?
Dec 08Would Boryung Pharmaceutical Co., Ltd. (KRX:003850) Be Valuable To Income Investors?
Nov 23Financial Position Analysis
Short Term Liabilities: A003850's short term assets (₩491.1B) exceed its short term liabilities (₩288.2B).
Long Term Liabilities: A003850's short term assets (₩491.1B) exceed its long term liabilities (₩151.3B).
Debt to Equity History and Analysis
Debt Level: A003850's net debt to equity ratio (29.5%) is considered satisfactory.
Reducing Debt: A003850's debt to equity ratio has reduced from 36.5% to 34.4% over the past 5 years.
Debt Coverage: A003850's debt is well covered by operating cash flow (31.2%).
Interest Coverage: A003850's interest payments on its debt are well covered by EBIT (8x coverage).